Genetic and epigenetic alterations in Toll like receptor 2 and wound healing impairment in type 2 diabetes patients
Introduction
The cascade of wound healing in higher organisms generally exhibits an integration of several mutually coherent steps ranging from (i) wound homeostasis through (ii) acute inflammation, (iii) proliferation and finally leading to (iv) remodeling of the affected part (Singh, Agrawal, Gupta, & Singh, 2013a). These steps should be tightly regulated spatially and temporally as any type of imbalance may lead to non healing chronic ulcers (Whitney, 2005). The immune system, both innate and adaptive, plays an integral function in the process of wound healing, as evident by the secretion of signaling molecules like cytokines, lymphokines and growth factors (Singer and Clark, 1999, Werner and Grose, 2003). Innate immune system provides the first line of defense against foreign invaders during the process of wound healing (Park & Barbul, 2004). Signaling receptors like Toll like receptors (TLRs) are one of the most prominent contributors for the induction of the innate immune and inflammation response (Takeda, Kaisho, & Akira, 2003). TLRs are the family of transmembrane proteins, expressed on almost every immune cell like macrophages, neutrophils and dendritic cells, where their main function is to serve as a pathogen recognizing receptor (PRR) and to sense the pathogen associated molecular patterns (PAMPs) over a plethora of microbes invading during open wounds (Akira, Uematsu, & Takeuchi, 2006). After binding with these PAMPs, TLRs initiate signaling pathways that ultimately lead to activation of two main transcription factors: Nuclear factor kB (NF-kB) or type I Interferon (IFN) (Dasu & Isseroff, 2012). The TLR induced inflammation may be either agonist or antagonist of wound healing, depending upon the timing and the extent of these transcription factors which critically determine the fate of the healing wound (Dasu & Isseroff, 2012).
TLR2 is an important extracellular member in mammalian Toll family of leucin rich receptors. TLR2 is known to be a signaling receptor for many microbial products including whole gram positive bacteria, microplasma, peptidoglycan and lipoteichoic acid derived from Gram-positive bacteria (Flo, Halaas, & Torp, 2001). Anti infectious property of TLR2 is evident from the fact that the TLR2-deficient mouse strain is more prone to infection with Gram-positive bacteria S. aureus and shows defective clearance of spirochetes after infection by Borrelia burgdorferi as compared to their wild type counterparts (Kuo et al., 2013). TLR2 has an ability to form heterophilic dimers with other structurally related TLRs like TLR1 and TLR6, due to which it can recognize a wide spectrum of microbial components. Alteration in the methylation pattern of TLR2 has been also described in certain epithelial diseases including carcinoma and cyst formation (Furuta et al., 2008). TLR2 has been shown to be a potent player in the wound healing mechanism. TLR2 activation after acute ischemic injury promotes the process of angiogenesis by inducing endothelial cell migration and adhesion to the wound site (Xu et al., 2013). TLR2 has been also shown to modulate the synthesis of Connexin-43 (Cx43), a gap junction protein, another potent wound healing agent (Ey, Eyking, & Gerken, 2009).
Persistent hyperglycemic microenvironment in type 2 diabetes mellitus (T2DM) leads to the development of secondary complications like cardiovascular disease, neuropathy, nephropathy, retinopathy and impairment of wound healing in patients. Wound healing impairment is a serious secondary complication of T2DM which contributes to a huge percentage of total amputations performed worldwide. As per recent data, around 25% of T2DM patients develop non healing wounds once in their life time (Singh, Agrawal, Gupta, & Singh, 2013b). The reason for this observation is that the hyperglycemic conditions in T2DM cases lead to decrease in cytokines and growth factors essential for healing of wounds (Werner & Grose, 2003). The immune response is also compromised in T2DM cases which generally leads to prolonged inflammation and unresolved infection in the wound microenvironment, thereby resulting in chronic wound which either takes a long time to heal or does not heal at all. TLRs are one of important members of immune system which is affected significantly in the T2DM individuals (Kanhaiya, Agrawal, Gupta, & Singh, 2013). Recently our group has shown that genetic and epigenetic alterations in TLRs, especially, TLR4 lead to impairment of wound healing in T2DM cases (Kanhaiya et al., 2013, Singh, Singh, Agrawal, Gupta and Singh, 2013, Singh, Singh, Agrawal, Gupta and Singh, 2014). In the present study we tried to look upon the expressional status of TLR2 in wounds of T2DM cases with respect to the severity of wounds. The methylation status of many CpG dinucleotides situated near the regulatory sequence in the promoter region of TLR2 gene was also examined to see the relationship of epigenetic regulation of TLR2 in the patho-physiology of diabetic wound healing impairment.
Section snippets
Subjects
In this hospital based case control study, a total of 110 lower extremity wounds of different grades were analyzed, out of which 102 were diabetic foot ulcer (DFU) cases and 8 were controls. Patients were recruited from the outpatient department (OPD) clinics and operation theaters of Department of Endocrinology and Metabolism and Department of Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India, during the period of July 2010 to December 2013. Patients were
Results
Semi quantitative RT-PCR data suggested that the mRNA transcripts of TLR2 were significantly down-regulated in DFU subjects compared to controls (p value = < 0.0001, t = 5.52, R squared = 0.22) (Fig. 2). The Quantitative RT-PCR results also indicated a similar down-regulation of TLR2 transcripts in the DFU cases compared to controls (p value = < 0.0001, t = 5.40, R squared = 0.21) (Fig. 3). Comparison between different grades of T2DM wounds suggested that the mRNA transcripts of TLR2 followed an increasing
Discussion
Susceptibility to T2DM and its secondary complications like DFU is multifactorial in nature and inappropriate activation of immune system and prolonged low grade inflammation may be one of them (Singh, Agrawal, et al., 2014, Singh, Kant, et al., 2014). In addition to playing a vital role in immunity, TLR2 is instrumental in coordinating tissue repair and regeneration (Ey et al., 2009). An array of current literature indicates that TLR2 is a potent modulator of wound healing in a time and
Acknowledgment
We would like to acknowledge the Real time PCR facility and Confocal facility from Interdisciplinary School of Life Science, BHU. We thank Nilu Prasad and Shanti Besra, Laboratory Superintendents, Indian Railway Cancer Hospital and Research Centre, N.E.R., Varanasi, for their technical assistance during IHC work. This work was funded by Department of Science and Technology, New Delhi, India. Financial assistance by the Department of Biotechnology, Ministry of Science and Technology, New Delhi,
References (26)
- et al.
Pathogen recognition and innate immunity
Cell
(2006) - et al.
Toll-like receptors in wound healing: Location, accessibility, and timing
Journal of Investigative Dermatology
(2012) - et al.
TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice
Laboratory Investigation
(2010) - et al.
TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury
The Journal of Biological Chemistry
(2009) - et al.
Activation of epidermal Toll-like receptor 2 enhances tight junction function: Implications for atopic dermatitis and skin barrier repair
Journal of Investigative Dermatology
(2013) Overview: Acute and chronic wounds
The Nursing Clinics of North America
(2005)- et al.
TLR2-independent induction and regulation of chronic intestinal inflammation
European Journal of Immunology
(2010) - et al.
Toll-like receptor expression and signaling in human diabetic wounds
World Journal of Diabetes
(2014) - et al.
TLR2 and TLR4 gene promoter methylation status during chronic periodontitis
Journal of Clinical Periodontology
(2011) - et al.
Differential expression of Toll-like receptor 2 in human cells
Journal of Leukocyte Biology
(2001)
DNA demethylation-dependent enhancement of Toll-like-receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcription
BMC Molecular Biology
Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages
Journal of Immunology
Up-regulation of TLR2 and TLR4 in dendritic cells in response to HIV type 1 and coinfection with opportunistic pathogens
AIDS Research and Human Retroviruses
Cited by (26)
Targeting DNA methylation and demethylation in diabetic foot ulcers
2023, Journal of Advanced ResearchRole of G-protein coupled receptor (GPCRs)/(GPR-120) as an agonists in diabetic wound healing
2022, Obesity MedicineCitation Excerpt :Early on, the latter transform into macrophages, which are regarded the primary cellular players of this inflammatory phase due to the production of growth factors and cytokines. Keratinocytes also move to the injured region, and local fibroblasts begin to proliferate (Balducci, Stefano, Sacchetti, Massimo, Haxhi, Jonida, Orlando, Giorgio, D'Errico, Valeria, Fallucca, Sara, Menini, Stefano, Pugliese, 2014; Barrientos et al., 2008; Bhora et al., 1995; Crovetti et al., 2004; Frank et al., 1995; Roberts, 1995; Sepehri et al., 2016; Singh et al., 2015a, 2015b; Smith et al., 2016). Closure of the wound is the goal of these stages.
Epigenetic basis of infectious diseases
2022, Viral, Parasitic, Bacterial, and Fungal Infections: Antimicrobial, Host Defense, and Therapeutic StrategiesEpigenetics of diabetic wound healing
2020, Wound Healing, Tissue Repair, and Regeneration in DiabetesMechanistic insight into diabetic wounds: Pathogenesis, molecular targets and treatment strategies to pace wound healing
2019, Biomedicine and PharmacotherapyCitation Excerpt :TLRs22 are important source for the initiation of the innate immune and inflammation response. Down regulation of TLRs-2 in injured tissue impairs or weakens the immune system and inflammation response [42–44] in diabetic patient which causes reduced chemotactic effect that delays the recruitment of various inflammatory cells. Diabetic patients are highly susceptible to infection caused by delayed wound healing and immuno-suppression [42].
Genetic and molecular basis of diabetic foot ulcers: Clinical review
2016, Journal of Tissue ViabilityCitation Excerpt :Wounds of diabetic patients take longer time to heal because of improper integration of angiogenesis, inflammation, expression of gap junction proteins, matrix metalloproteinases (MMPs) and disordered immune response, majority of which are also governed by toll-like receptor 2 (TLR2) expression [22,23]. It has been demonstrated that the TLR2 mediated signalling is essential for acute inflammation following microbial invasion but has no role in regulating the induction of chronic inflammation supporting the evidence that TLR2 promotes angiogenesis after acute ischemic injury by promoting endothelial cell migration, modulating their permeability and their invasion by lymphocytes [22]. Another report by Ey et al. demonstrated that TLR2 is important in synthesis of Cx43 in epithelial cells which helps in the formation of tight junctions and any deficiency of TLR2 signalling cause epithelial cell specific alterations in Cx43 expression [24].
Conflict of interest: The authors declare that they have no conflict of interest.